Aneurysm Neck Occlusion Member for Stable Intrasaccular Sealing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for intracranial aneurysms, such as platinum coil placement and flow diverters, face challenges with long-term recanalization and the need for antiplatelet therapy, which can be risky, especially in cases with wide necks or large volumes, necessitating a more effective and immediate solution.

Innovation Solution

A method involving positioning an expandable occlusive member within the aneurysm and introducing an embolic element to deform the occlusive member, creating a stable seal at the neck, which provides structural support, diverts blood flow, and facilitates tissue remodeling, while also serving as a scaffold for thrombus formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If platinum coils are disposed within the aneurysm interior volume, then thrombus formation is induced and aneurysm rupture risk is reduced, but long-term recanalization occurs especially in aneurysms with wide necks and large interior volumes

Engineering Contradiction:
Improveaneurysm occlusion stabilityVSAvoidtime to achieve complete occlusion
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The occlusive member is deployed in advance to immediately seal the aneurysm neck, creating a preliminary barrier that prevents blood flow into the aneurysm interior. This preliminary action achieves immediate neck closure rather than waiting for thrombus formation, thereby preventing recanalization while still allowing time for thrombus development within the sealed aneurysm sac.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The treatment is divided into two functional components: the occlusive member that seals the neck and the embolic material that fills the interior volume. This segmentation allows the neck closure function to be performed immediately by the occlusive member while the embolic material provides additional security against recanalization, addressing both the immediate and long-term occlusion requirements.

Inventive Principle:
Principle #1Segmentation

2Reliability

If flow diverters are deployed to cause blood to preferentially flow along the main channel, then aneurysm thrombus formation occurs, but it takes weeks or months to form thrombus and significantly longer for endothelial coverage

Engineering Contradiction:
Improveaneurysm occlusion stabilityVSAvoidtime to achieve full occlusion effect
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The occlusive member performs the critical neck sealing action immediately upon deployment, rather than waiting for the slow process of thrombus formation and endothelialization that characterizes flow diverter treatment. This preliminary neck closure provides immediate protection against rupture while the slower biological processes complete the occlusion.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention replaces the reliance on slow biological processes (thrombus formation and endothelialization) with an immediate mechanical action (occlusive member deployment) to achieve neck closure. This mechanical substitution provides immediate occlusion effect rather than waiting weeks or months for biological healing.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If flow diverters are used to treat aneurysms, then thrombus formation in the aneurysm is promoted, but antiplatelet therapy is required which increases risk of re-rupture after initial rupture

Engineering Contradiction:
Improveaneurysm occlusion stabilityVSAvoidrisk of re-rupture
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts the critical occlusion function from the flow diverter device and concentrates it in the occlusive member deployed at the aneurysm neck. By taking out the essential neck sealing function and performing it immediately with the occlusive member, the system eliminates the need for flow diverters and their associated antiplatelet therapy requirements, thereby reducing re-rupture risk.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The occlusive member performs preliminary neck closure before any thrombus formation occurs, eliminating the need for antiplatelet therapy that would be required with flow diverters. This preliminary mechanical sealing provides immediate protection without the harmful side effects of antiplatelet medications.

Inventive Principle:
Principle #10Preliminary action

4Ease of operation

If conventional vascular surgery is performed with microcatheter coil placement, then the procedure is minimally invasive, but recanalization occurs in cases with wide necks and large interior volumes

Engineering Contradiction:
Improveminimally invasive procedureVSAvoidaneurysm occlusion stability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The invention merges the minimally invasive delivery approach with the immediate mechanical occlusion effect of the expandable occlusive member. The occlusive member is delivered through a catheter system (maintaining minimally invasive access) but provides immediate neck sealing and recanalization prevention (improving occlusion stability), combining the advantages of both approaches.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The occlusive member transitions from a compressed delivery state to an expanded deployed state within the aneurysm, dynamically changing its configuration to achieve the occlusion effect. This dynamic transformation allows the device to be delivered minimally invasively while providing immediate and stable occlusion upon deployment.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS12256936B2Devices, systems, and methods for treatment of intracranial aneurysms
Publication Date: 2025.03.25 COVIDIEN LP
  • US12256936B2 patent drawing
  • US12256936B2 patent drawing
  • US12256936B2 patent drawing

AI summary

Systems and methods for treating an aneurysm in accordance with embodiments of the present technology include intravascularly delivering an occlusive member to an aneurysm cavity and deforming a shape of the occlusive member via introduction of an embolic element to a space between the occlusive member and an inner surface of the aneurysm wall.